Therefore, it is likely that an attenuation of the impact of glucagon to support postabsorptive endogenous glucose production and glycemia occurs in individuals with T2DM associated with obesity. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.